News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,640 Results
Type
Article (2168)
Company Profile (13)
Press Release (32459)
Section
Business (12616)
Career Advice (138)
Deals (1465)
Drug Development (4608)
Employer Resources (1)
FDA (678)
Job Trends (821)
News (19289)
Policy (1260)
Tag
Academia (176)
Accelerated approval (1)
Adcomms (2)
Allergies (3)
Alliances (3568)
ALS (1)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (7)
Approvals (676)
Artificial intelligence (20)
Automation (1)
Bankruptcy (4)
Best Places to Work (729)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (10)
Bladder cancer (16)
Brain cancer (1)
Breast cancer (14)
Cancer (125)
Cardiovascular disease (8)
Career advice (115)
Career pathing (2)
CAR-T (3)
Cell therapy (12)
Clinical research (3703)
Collaboration (67)
Compensation (19)
Complete response letters (6)
COVID-19 (112)
CRISPR (4)
C-suite (18)
Cystic fibrosis (5)
Data (144)
Depression (1)
Diabetes (14)
Diagnostics (427)
Digital health (2)
Drug discovery (15)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (3210)
Employer resources (1)
Events (4251)
Executive appointments (93)
FDA (742)
Funding (44)
Gene editing (7)
Generative AI (4)
Gene therapy (15)
GLP-1 (42)
Government (128)
Guidances (5)
Healthcare (565)
Huntington's disease (4)
Immunology and inflammation (7)
Indications (1)
Infectious disease (120)
Inflammatory bowel disease (10)
Influenza (6)
Intellectual property (6)
Interviews (17)
IPO (604)
IRA (1)
Job creations (142)
Job search strategy (108)
Labor market (2)
Layoffs (14)
Leadership (1)
Legal (130)
Liver cancer (10)
Lung cancer (14)
Lymphoma (5)
Machine learning (1)
Management (1)
Manufacturing (34)
MASH (22)
Medical device (296)
Medtech (296)
Mergers & acquisitions (898)
Metabolic disorders (61)
Multiple sclerosis (1)
NASH (4)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (72)
NextGen: Class of 2025 (265)
Non-profit (165)
Now hiring (6)
Obesity (23)
Opinion (11)
Ovarian cancer (5)
Pain (3)
Pancreatic cancer (4)
Parkinson's disease (4)
Partnered (1)
Patents (13)
Patient recruitment (3)
Peanut (2)
People (5364)
Pharmaceutical (5)
Phase I (1317)
Phase II (1514)
Phase III (1246)
Pipeline (108)
Policy (2)
Postmarket research (101)
Preclinical (642)
Press Release (3)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (20)
Rare diseases (21)
Real estate (414)
Regulatory (1110)
Reports (1)
Research institute (118)
Resumes & cover letters (17)
RNA editing (1)
RSV (2)
Series A (13)
Series B (4)
Sickle cell disease (3)
Spinal muscular atrophy (13)
Sponsored (1)
Startups (299)
Supply chain (3)
Vaccines (18)
Venture capitalists (1)
Weight loss (6)
Women's health (1)
Worklife (3)
Date
Today (4)
Last 7 days (55)
Last 30 days (158)
Last 365 days (2042)
2025 (669)
2024 (2183)
2023 (2425)
2022 (3041)
2021 (3090)
2020 (2539)
2019 (2144)
2018 (1591)
2017 (1984)
2016 (1643)
2015 (1937)
2014 (1488)
2013 (1087)
2012 (1177)
2011 (1462)
2010 (1185)
Location
Africa (28)
Alabama (5)
Arizona (1)
Arkansas (1)
Asia (2329)
Australia (316)
California (445)
Canada (93)
China (22)
Colorado (16)
Connecticut (28)
Delaware (11)
Europe (6155)
Florida (16)
Georgia (18)
Idaho (1)
Illinois (17)
India (2)
Indiana (89)
Iowa (1)
Japan (10)
Kansas (1)
Maine (3)
Maryland (29)
Massachusetts (329)
Michigan (3)
Minnesota (30)
Missouri (1)
Montana (1)
New Hampshire (1)
New Jersey (99)
New York (95)
North Carolina (40)
North Dakota (1)
Northern California (226)
Ohio (14)
Oklahoma (3)
Oregon (3)
Pennsylvania (41)
Puerto Rico (1)
Rhode Island (1)
South America (48)
South Carolina (1)
Southern California (149)
Tennessee (2)
Texas (21)
United States (1396)
Utah (22)
Virginia (4)
Washington D.C. (1)
Washington State (41)
Wisconsin (2)
34,640 Results for "alfa chemistry".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
April 28, 2025
·
9 min read
Press Releases
PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage
March 5, 2025
·
4 min read
Press Releases
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
April 28, 2025
·
8 min read
Press Releases
Boston Pharmaceuticals to Present the Effect of Efimosfermin Alfa on Collagen Biomarkers in Patients with F2 and F3 MASH at EASL Congress 2025
April 28, 2025
·
6 min read
Press Releases
Marengo Presents Expanded Clinical Monotherapy Activity of Invikafusp Alfa in Multiple PD-1 Resistant Tumors as a Clinical Plenary Oral at AACR 2025
April 29, 2025
·
6 min read
Press Releases
Boston Pharmaceuticals to Present State-of-the-Art Lecture and Poster for Once-monthly Efimosfermin Alfa at Digestive Disease Week® 2025
April 23, 2025
·
7 min read
Press Releases
Ankyra Therapeutics Announces Phase 1 Clinical Data at the 2025 AACR Annual Meeting and the first patient has been dosed with tolododekin alfa and cemiplimab
April 28, 2025
·
4 min read
Press Releases
Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
April 15, 2025
·
7 min read
Press Releases
Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera
March 20, 2025
·
4 min read
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
1 of 3,464
Next
